Vianney Tricou, PharmD, DPhil - Takeda Pharmaceutical Company - Associate Medical Director Dengue

Vianney Tricou

PharmD, DPhil

Takeda Pharmaceutical Company

Associate Medical Director Dengue

Zurich | Switzerland

Main Specialties: Infectious Disease

ORCID logohttps://orcid.org/0000-0002-5465-8647

Vianney Tricou, PharmD, DPhil - Takeda Pharmaceutical Company - Associate Medical Director Dengue

Vianney Tricou

PharmD, DPhil

Introduction

Vianney Tricou is a Clinical Development professional specialized in Infectious Diseases. He is currently Associate Medical Director at the Vaccine Business Unit of Takeda, working toward the development of TAK-003, a novel dengue tetravalent vaccine candidate. He is based in Zurich, Switzerland.

Primary Affiliation: Takeda Pharmaceutical Company - Zurich , Switzerland

Specialties:

Research Interests:

Education

Jan 2007 - Nov 2012
University of Oxford
DPhil
Oxford University Clinical Research Unit - Ho Chi Minh City, Viet Nam
Jan 1998 - May 2010
Université Claude Bernard Lyon 1
PharmD
Faculté de Pharmacie - Institut des Sciences Pharmaceutiques et Biologiques
Jan 2005 - Jun 2006
Université Paris VII Denis Diderot UFR Sciences du Vivant
MSc in Bioinformatics
Equipe de Bioinformatique Génomique et Moléculaire (EBGM)

Publications

25Publications

1071Reads

62Profile Views

Tetravalent Dengue Vaccine in Healthy Children. Reply.

N Engl J Med 2020 04;382(18):1770-1771

Takeda Vaccines, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2000987DOI Listing
April 2020
55.873 Impact Factor

Hepatitis E virus outbreak associated with rainfall in the Central African Republic in 2008-2009.

BMC Infect Dis 2020 Apr 3;20(1):260. Epub 2020 Apr 3.

Laboratoire des Hépatites Virales, Institut Pasteur, Bangui, Central African Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-020-04961-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119096PMC
April 2020
2.613 Impact Factor

Complete Genome Sequences of Igbo-Ora and Babanki Alphavirus Strains Isolated in the Central African Republic in the 1960s and 1970s.

Microbiol Resour Announc 2019 Oct 10;8(41). Epub 2019 Oct 10.

Institut Pasteur, Epidemiology and Physiopathology of Oncogenic Viruses, CNRS UMR3569, Paris, France.

View Article

Download full-text PDF

Source
http://genomea.asm.org/lookup/doi/10.1128/MRA.00868-19
Publisher Site
http://dx.doi.org/10.1128/MRA.00868-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787323PMC
October 2019
5 Reads

Complete Genome Sequences of Two Chikungunya Viruses Isolated in the Central African Republic in the 1970s and 1980s.

Genome Announc 2017 Mar 2;5(9). Epub 2017 Mar 2.

Institut Pasteur, Epidemiology and Physiopathology of Oncogenic Viruses, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/genomeA.00003-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334572PMC
March 2017
23 Reads

Genetic characterization of Chikungunya virus in the Central African Republic.

Infect Genet Evol 2015 Jul 22;33:25-31. Epub 2015 Apr 22.

Virology Department, Institut Pasteur de Bangui, Bangui, Central African Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.meegid.2015.04.006DOI Listing
July 2015
30 Reads
3.015 Impact Factor

Complete genome sequences of two middelburg viruses isolated from arthropods in the central african republic.

Genome Announc 2014 Oct 23;2(5). Epub 2014 Oct 23.

Department of Virology, Institut Pasteur de Bangui, Bangui, Central African Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/genomeA.01078-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208332PMC
October 2014
11 Reads

Within-host viral dynamics of dengue serotype 1 infection.

J R Soc Interface 2014 Jul;11(96)

Department for Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College, London W2 1PG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1098/rsif.2014.0094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032531PMC
July 2014
35 Reads

Complete genome sequence of a rabies virus isolated from a human in central african republic.

Genome Announc 2014 Jun 19;2(3). Epub 2014 Jun 19.

Department of Virology, Institut Pasteur de Bangui, Bangui, Central African Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/genomeA.00598-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064799PMC
June 2014
7 Reads

Measles outbreak in Northern Central African Republic 3 years after the last national immunization campaign.

BMC Infect Dis 2013 Feb 26;13:103. Epub 2013 Feb 26.

Institut Pasteur de Bangui, Bangui, Central African Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2334-13-103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599156PMC
February 2013
151 Reads
2.613 Impact Factor

Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.

PLoS Negl Trop Dis 2011 Sep 6;5(9):e1309. Epub 2011 Sep 6.

Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Program, Ho Chi Minh City, Viet Nam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0001309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167785PMC
September 2011
8 Reads

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

PLoS Negl Trop Dis 2010 Aug 10;4(8):e785. Epub 2010 Aug 10.

Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0000785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919376PMC
August 2010
22 Reads

Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses.

BMC Infect Dis 2010 May 28;10:142. Epub 2010 May 28.

Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 190 Ben Ham Tu, District 5, Ho Chi Minh City, Viet Nam.

View Article

Download full-text PDF

Source
http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-
Publisher Site
http://dx.doi.org/10.1186/1471-2334-10-142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895602PMC
May 2010
26 Reads
2.613 Impact Factor

Top co-authors

Emmanuel Nakoune
Emmanuel Nakoune

Institut Pasteur de Bangui

9
Mirdad Kazanji
Mirdad Kazanji

University of Kansas Medical Center

9
Cameron P Simmons
Cameron P Simmons

Oxford University Clinical Research Unit

6
Astrid Borkowski
Astrid Borkowski

University of Tampere Medical School

5
Derek Wallace
Derek Wallace

University of Glasgow

5
Jeremy Farrar
Jeremy Farrar

Oxford University Clinical Research Unit

5
Martina Rauscher
Martina Rauscher

University of Colorado

3
Manja Brose
Manja Brose

University of Modena and Reggio Emilia

3
Bridget Wills
Bridget Wills

Oxford University Clinical Research Unit

3